A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

In the M-ACCEL trial, HU6-induced weight loss was exclusively attributed to fat loss, with no statistically significant loss ...

New GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India's top endocrinologist, in an episode of Booked, highlights the impact of ...

Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Mounjaro users in the UK have to jump through quite a few hoops to get their hands on the weight-loss drug. You might think ...

In this Newshour Special Edition, Navika Kumar speaks to India’s top endocrinologist Dr Ambrish Mithal on the country’s ...

GPs will be prescribing Mounjaro to a select few people as the rollout begins, but others may need to avoid the jabs ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.

The GLP-1 drugs, including Mounjaro and Wegovy, work by mimicking the action of hormones that make you feel full, while ...

There are a few potential risks to keep in mind with rice water, including some food safety concerns.